NASDAQ : MMED
Minimed Group, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 18.28 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.14B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.30B |
| Enterprise Value | 5.16B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 281.35M |
| Shares Outstanding | 281.35M |
| Shares Change (YoY) | +4.29% |
| Shares Change (QoQ) | +4.81% |
| Owned by Insiders (%) | 0.03% |
| Owned by Institutions (%) | 13.64% |
| Float | 281.27M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 31.12 |
| PS Ratio | 1.61 |
| Forward PS | 1.50 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 4.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.57 |
| EV / EBITDA | 17.67 |
| EV / EBIT | 39.49 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.81 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -8.66% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 2.26% |
| Return on Capital Employed (ROCE) | 3.25% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $402,750 |
| Profits Per Employee | -$39,250 |
| Employee Count | 8,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 129.00M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 20.12 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 49.01 |
| Average Volume (20 Days) | 17,553,333 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 20.70M |
| Short Previous Month | 18.20M |
| Short % of Shares Out | 7.36% |
| Short % of Float | 7.36% |
| Short Ratio (days to cover) | 1.61 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.22B |
| Gross Profit | 1.83B |
| Operating Income | 128.00M |
| Pretax Income | -172.00M |
| Net Income | -314.00M |
| EBITDA | 286.00M |
| EBIT | 128.00M |
| Loss Per Share | -$1.19 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 207.00M |
| Total Debt | 59.00M |
| Net Cash | 148.00M |
| Net Cash Per Share | $0.53 |
| Equity (Book Value) | 3.62B |
| Book Value Per Share | 12.87 |
| Working Capital | 635.00M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -105.00M |
| Capital Expenditures | -211.00M |
| Depreciation & Amortization | 158.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -316.00M |
| FCF Per Share | -$1.12 |
Margins
| Measure | Value |
|---|
| Gross Margin | 56.89% |
| Operating Margin | 3.97% |
| Pretax Margin | -5.34% |
| Profit Margin | -9.75% |
| EBITDA Margin | 8.88% |
| EBIT Margin | 3.97% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.29% |
| Shareholder Yield | -4.29% |
| Earnings Yield | -6.33% |
| FCF Yield | -6.07% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $25.47 |
| Price Target Difference | 35.08% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 9.75% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.12 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |